142 related articles for article (PubMed ID: 17312045)
1. Practical approach to diagnostic CT combined with PET.
Wong TZ; Paulson EK; Nelson RC; Patz EF; Coleman RE
AJR Am J Roentgenol; 2007 Mar; 188(3):622-9. PubMed ID: 17312045
[TBL] [Abstract][Full Text] [Related]
2. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ;
J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET CT for tumor imaging.
Miller JC; Fischman AJ; Aquino SL; Blake MA; Thrall JH; Lee SI
J Am Coll Radiol; 2007 Apr; 4(4):256-9. PubMed ID: 17412280
[No Abstract] [Full Text] [Related]
4. PET/CT: challenge for nuclear cardiology.
Schwaiger M; Ziegler S; Nekolla SG
J Nucl Med; 2005 Oct; 46(10):1664-78. PubMed ID: 16204717
[TBL] [Abstract][Full Text] [Related]
5. Acquisition protocol considerations for combined PET/CT imaging.
Beyer T; Antoch G; Müller S; Egelhof T; Freudenberg LS; Debatin J; Bockisch A
J Nucl Med; 2004 Jan; 45 Suppl 1():25S-35S. PubMed ID: 14736833
[TBL] [Abstract][Full Text] [Related]
6. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
7. Sources and resources for oncologists to help answer the question: is PET/CT appropriate for my patient?
Karantanis D; Allen-Auerbach M; Czernin J
Hell J Nucl Med; 2012; 15(1):2-8. PubMed ID: 22413105
[TBL] [Abstract][Full Text] [Related]
8. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
[TBL] [Abstract][Full Text] [Related]
9. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
10. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
[TBL] [Abstract][Full Text] [Related]
11. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls.
Chong S; Lee KS; Kim HY; Kim YK; Kim BT; Chung MJ; Yi CA; Kwon GY
Radiographics; 2006; 26(6):1811-24; discussion 1824-6. PubMed ID: 17102052
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in PET/CT interpretation.
Cook GJ
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):235-43. PubMed ID: 17464270
[TBL] [Abstract][Full Text] [Related]
13. CT in PET/CT: essential features of interpretation.
Schöder H; Yeung HW; Larson SM
J Nucl Med; 2005 Aug; 46(8):1249-51. PubMed ID: 16085577
[No Abstract] [Full Text] [Related]
14. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients.
Osman MM; Cohade C; Fishman EK; Wahl RL
J Nucl Med; 2005 Aug; 46(8):1352-5. PubMed ID: 16085594
[TBL] [Abstract][Full Text] [Related]
15. PET-CT in oncology: making the most of CT.
Miles KA
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S87-93. PubMed ID: 18852084
[TBL] [Abstract][Full Text] [Related]
16. Pediatric PET/CT imaging: tips and techniques.
McQuattie S
J Nucl Med Technol; 2008 Dec; 36(4):171-80. PubMed ID: 19008284
[TBL] [Abstract][Full Text] [Related]
17. PET/CT image navigation and communication.
Ratib O
J Nucl Med; 2004 Jan; 45 Suppl 1():46S-55S. PubMed ID: 14736835
[TBL] [Abstract][Full Text] [Related]
18. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
[TBL] [Abstract][Full Text] [Related]
20. Added value of PET and PET-CT in oesophageal cancer: a review of current practice.
Vinjamuri S; Ray S
Nucl Med Commun; 2008 Jan; 29(1):4-10. PubMed ID: 18049091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
